Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$3.32B |
| 2 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$975M |
| 3 |
AABA
Altaba Inc
AABA
|
+$871M |
| 4 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$372M |
| 5 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$338M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.62B |
| 2 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$1.02B |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$860M |
| 4 |
Microsoft
MSFT
|
+$594M |
| 5 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$517M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.12% |
| 2 | Healthcare | 4.92% |
| 3 | Financials | 4.07% |
| 4 | Consumer Discretionary | 3.64% |
| 5 | Communication Services | 3.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
CALL
Boeing
BA
$171B
| $39.6M | 0.04% |
200,100
+71,900
| +56% | +$13.4M |
|
352
CALL
MetLife
MET
$61.9B
| $39.5M | 0.04% |
806,830
+290,486
| +56% | +$13.5M |
|
|
JWN
353
PUT
DELISTED
Nordstrom
JWN
| $39.4M | 0.04% |
824,000
+754,200
| +1,081% | +$34.3M |
|
354
PUT
Blackstone
BX
$102B
| $39.4M | 0.04% |
1,180,800
+692,900
| +142% | +$21.7M |
|
|
ALXN
355
CALL
DELISTED
Alexion Pharmaceuticals
ALXN
| $39.4M | 0.04% |
323,500
-88,400
| -21% | -$10.3M |
|
356
VanEck Oil Services ETF
OIH
$2.06B
| $39.3M | 0.04% |
79,311
-28,751
| -27% | -$15.7M |
|
357
Cigna
CI
$73.7B
| $39.2M | 0.04% |
234,000
+1,060
| +0.5% | +$170K |
|
358
CALL
Teva Pharmaceuticals
TEVA
$40.8B
| $38.8M | 0.04% |
1,169,200
+796,100
| +213% | +$24.6M |
|
359
TJX Companies
TJX
$174B
| $38.8M | 0.04% |
1,075,608
+232,876
| +28% | +$8.78M |
|
|
CELG
360
PUT
DELISTED
Celgene Corp
CELG
| $38.7M | 0.04% |
298,000
+44,500
| +18% | +$5.45M |
|
361
PUT
Palo Alto Networks
PANW
$270B
| $38.3M | 0.04% |
1,719,000
+17,400
| +1% | +$352K |
|
362
Workday
WDAY
$39.6B
| $38.3M | 0.04% |
394,641
+25,551
| +7% | +$2.39M |
|
|
363
CALL
Palo Alto Networks
PANW
$270B
| $38.2M | 0.04% |
1,714,800
+1,556,400
| +983% | +$31.4M |
|
|
GAP
364
The Gap Inc
GAP
$7.23B
| $38.2M | 0.04% |
1,737,745
+866,701
| +100% | +$20.6M |
|
365
Welltower
WELL
$169B
| $38.2M | 0.04% |
510,318
+114,649
| +29% | +$8.38M |
|
366
CALL
Merck
MRK
$322B
| $38.2M | 0.04% |
623,979
-148,607
| -19% | -$9.05M |
|
367
Ventas
VTR
$48B
| $37.9M | 0.04% |
545,088
+356,320
| +189% | +$23.7M |
|
368
Humana
HUM
$43.7B
| $37.9M | 0.04% |
157,325
-547,741
| -78% | -$124M |
|
369
CALL
Qualcomm
QCOM
$155B
| $37.6M | 0.04% |
680,300
-204,400
| -23% | -$11.4M |
|
370
PUT
Intel
INTC
$455B
| $37.5M | 0.04% |
1,111,800
-1,816,400
| -62% | -$65M |
|
|
VER
371
DELISTED
VEREIT, Inc.
VER
| $37.4M | 0.04% |
918,678
+631,936
| +220% | +$26.1M |
|
372
PUT
Comcast
CMCSA
$85B
| $37.3M | 0.04% |
959,000
+454,000
| +90% | +$17.9M |
|
373
Prudential Financial
PRU
$42.4B
| $37.1M | 0.04% |
343,354
+19,566
| +6% | +$2.08M |
|
374
State Street SPDR S&P Biotech ETF
XBI
$9.95B
| $36.9M | 0.04% |
478,134
-72,788
| -13% | -$5.16M |
|
375
Regeneron Pharmaceuticals
REGN
$78.5B
| $36.8M | 0.04% |
75,025
+6,990
| +10% | +$3.06M |
|
Similar funds
Barclays's Q2 2017 Portfolio in Review
As of Q2 2017, Barclays held 7,324 positions worth $93.4B, up 1.6% from $91.9B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Barclays's Q2 2017 filing shows 436 new, 3,303 increased, 2,734 reduced and 395 closed positions. Its largest new stake was Altaba Inc: 16,007,195 shares worth $872M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.62B.
By sector, the portfolio is most concentrated in Technology at 6.1% of assets, up from 5.7% a quarter earlier, followed by Healthcare and Financials.
- Barclays's largest Q2 2017 buy was Altaba Inc: 16,007,195 shares worth $872M.
- Barclays added most to Invesco QQQ Trust in Q2 2017, an estimated $3.32B increase.
- Barclays's biggest Q2 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.62B.
- Barclays fully exited Yahoo Inc in Q2 2017, selling an estimated $174M.
- Barclays's ten largest holdings make up 32% of its $93.4B portfolio in Q2 2017.
- Barclays opened 436 new positions and closed 395 in Q2 2017.
- Barclays's portfolio value rose 1.6% quarter-over-quarter to $93.4B.
Based on Barclays's 13F filing for Q2 2017, filed 14 Aug 2017.